GrowGeneration Corp Stock News

GrowGeneration Corp. ( GRWG ) Q3 2025 Earnings Call November 6, 2025 4:30 PM EST Company Participants Darren Lampert - Co-Founder, CEO & Chairperson of the Board Greg Sanders - Chief Financial Officer Conference Call Participants Phil Carlson - Kanan, Corbin, Schupak & Aronow, Inc. Aaron Grey - Alliance Global Partners, Research Division Presentation Operator Hello, everyone, and welcome to Gro...

Marijuana stocks are still in trying to reach better trading levels. This could happen in several ways, one of which is reform, as many are waiting to see what unfolds. In the US, there has been a push for more legal states and the end of cannabis prohibtion. Over the last half-decade, as federal reform has been pushed forward, it has had a positive impact on marijuana stocks.

Although reform has been the biggest market mover for marijuana stocks, earnings could have a similar impact. Companies are planning on reporting their Q3 2025 earnings. If these financial reports continue to exceed expectations for some companies, this could set off some upward trading. At times when several marijuana stocks begin to trade well, this speculation leads to more trading in the se...

DENVER, Oct. 23, 2025 (GLOBE NEWSWIRE) -- GrowGeneration Corp. (NASDAQ: GRWG) (“GrowGen” or the “Company”), the nation's largest specialty hydroponic and organic gardening retailer, today announced it will release its financial results for the third quarter ended September 30, 2025, on Thursday, November 6, 2025, after market close. The announcement will be followed by a live earnings conferenc...

The U.S. cannabis industry continues to grow rapidly as legalization momentum spreads across new states. According to recent data, the market is projected to exceed $35 billion in annual sales by 2025. Additionally, analysts expect the industry to reach over $70 billion by 2030 as federal reform progresses. Last week, renewed discussions in Congress surrounding cannabis rescheduling lifted inve...

Most marijuana stock investors are keeping a core focus on the future. At one point in time, most cannabis stocks had fast turnarounds for making a profit. However, this has not been the case for a long while. In fact, since the pandemic, there has been an overwhelming drop in trading in that sector. Now, with a bigger push for federal reform and other rules and regulatory issues being worked o...

The U.S. cannabis industry is gaining momentum again, and ancillary stocks are attracting investor attention this week. The legal market generated over $30 billion in sales last year and could exceed $50 billion by 2030. Ancillary companies provide vital tools, marketplaces, and supplies, making them less exposed to direct regulation. Recent headlines highlight renewed discussions in Congress a...

The U.S. cannabis industry continues to expand, with annual sales expected to surpass 40 billion dollars in 2025. Market forecasts suggest long-term growth as more states approve medical and recreational use. Recent discussions on federal legalization have also reignited investor interest. These developments provide a favorable backdrop for ancillary companies, which support the industry withou...